About Personal Genomics
Personal Genomics is a Healthcare company based in Verona (Italy) founded in 2011, and was acquired by SOL Group in June 2017. Personalized genome analysis and health risk assessments are provided. Personal Genomics offers products and services including NGS Services, Gene Panels, and Predictive Tests. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its legal entity is Personal Genomics unipersonale Srl.
Company details
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals. The companys consumer genomics services include personalized genome analysis for prediction of adverse drug response, clinical exome and whole-genome sequencing, Myocardial Infarction Risk assessment (MI Risk kit), high blood pressure, and cardiovascular disease risk assessment (Col Risk Kit) using genetic variants associated with the levels of LDL and HDL cholesterol and a non-invasive prenatal test (NIPT - Prenatal Insight).
- Headquarters Verona, Italy
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website personalgenomics.it/en/?noredirect=en_US
- Social LinkedIn X Facebook
- Acquired by SOL Group (Jun 2017)
- Legal Name Personal Genomics Unipersonale Srl
- Latest Funding Round$263.59K (USD), Grant
May 2022
- InvestorsEuropean Union
& 1 more
- Acquired bySOL Group
(Jun 2017)
Products & Services of Personal Genomics
Personal Genomics offers a comprehensive portfolio of products and services, including NGS Services, Gene Panels, and Predictive Tests.
Custom sequencing for research and diagnostics purposes
Personalized panels for frequent clinical situations
Tests for diseases like cardiovascular and prenatal conditions
Funding Insights of Personal Genomics
- Total Rounds 5
- Last Round Grant — $263,594
- First Round $718,094
(Sep 2015)
- Investors Count 1
All 5 funding rounds of Personal Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $263,594 | Grant | – | – | |
| Jan 2021 | $213,087 | Grant | – | – | |
| Jun 2016 | $391,049 | Grant | – | – | |
| Jan 2016 | $280,254 | Grant | – | – | |
| Sep 2015 | $718,094 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Personal Genomics
Personal Genomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and SOL Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Provider of technical, pure and medical gases and home care service | 1927 | solgroup.com | Monza, Italy |
Investor details for Personal Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Personal Genomics
4 dated milestones of Personal Genomics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Personal Genomics is founded.
- Funding First funding round of $718K.
- Exit Acquired by SOL Group.
- Funding Latest funding round, Grant, of $264K.
Web traffic of Personal Genomics
The website of Personal Genomics (personalgenomics.it) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 56.4% vs previous month
Websites whose visitors overlap most with Personal Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
newchemspa.com | newchemspa.com | 100% | – | ||
| microbion.it | 95% | View details | |||
| sibyllabiotech.it | 95% | 1.3K | #11,298,379 | View details | |
agqlabs.it | agqlabs.it | 94% | #6,814,225 | – | |
irmed.it | irmed.it | 91% | #8,779,748 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Personal Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Personal Genomics
Personal Genomics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Personal Genomics is headquartered in Verona, Italy. It is registered at Verona, Veneto, Italy.
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals. The companys consumer genomics services include personalized genome analysis for prediction of adverse drug response, clinical exome and whole-genome sequencing, Myocardial Infarction Risk assessment (MI Risk kit), high blood pressure, and cardiovascular disease risk assessment (Col Risk Kit) using genetic variants associated with the levels of LDL and HDL cholesterol and a non-invasive prenatal test (NIPT - Prenatal Insight).
Personal Genomics offers NGS Services, Gene Panels, and Predictive Tests.
Personal Genomics has 2 investors. Key investors include European Union, and SOL Group.
Personal Genomics operates through Personal Genomics Unipersonale Srl.
Yes. Personal Genomics was acquired by SOL Group in June 2017.